Tumor Growth Suppression With Novel Intra-arterial Chemotherapy Using Epirubicin-entrapped Water-in-oil-in-water Emulsion In Vivo

Conclusion: WOW-Epi led to tumour growth suppression in vivo. WOW does not cause toxicity to arterial vessels. WOW-Epi will be hopefully used for repeated intra-arterial chemotherapy to HCC patients in the near future.

Source: In Vivo - January 5, 2021 Category: Research Authors: YANAGIE, H., FUJINO, T., YANAGAWA, M., TERAO, T., IMAGAWA, T., FUJIHARA, M., MORISHITA, Y., MIZUMACHI, R., MURATA, Y., DEWI, N., ONO, Y., IKUSHIMA, I., SEGUCHI, K., NAGATA, M., NONAKA, Y., FURUYA, Y., HISA, T., NAGASAKI, T., ARIMORI, K., NAKASHIMA, T., SU Tags: Experimental Studies Source Type: research